Familial Ovarian Carcinoma — Clinical Trials

MONDO:01005143 activeLast updated: Mar 19, 2026, 12:40 AM

Trial Landscape

Familial Ovarian Carcinoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment1

Procedure1

Biological Therapy1

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

2 trials are observational or have no phase designation.

Sponsor Types

Academic/Other3

Trial Locations

United States3 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 1Active, Not Recruiting

NCT04673448

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

Sponsor:University of Washington

United StatesStarted: Oct 2021Est. completion: Sep 2026Updated: Jan 2026

Not ApplicableActive, Not Recruiting

NCT01230346

Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

Sponsor:City of Hope Medical Center

United StatesStarted: Sep 2010Est. completion: Sep 2026Updated: Nov 2025

Not ApplicableActive, Not Recruiting

NCT04125914

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

Sponsor:M.D. Anderson Cancer Center

United StatesStarted: Jan 2017Est. completion: Apr 2026Updated: Nov 2025

Stay informed about clinical trials for Familial Ovarian Carcinoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 12:40 AM